In Reply Drs Wilkinson and Sanacora propose broader distribution of authorship credit to augment involvement of academic researchers in randomized clinical trials (RCTs) and boost the multicenter evaluation of “preventive, diagnostic, and therapeutic interventions.” Despite current stringent authorship guidelines, data suggest that the number of mainly industry-sponsored, multinational RCTs is increasing, as are the proportions of large RCTs recruiting patients in 3 or more to more than 10 nations and more than 1 continent.1-3 These data suggest expansion of international collaborative networks associated with well-designed research projects to provide high-quality published evidence on potentially beneficial interventions.1
Mentzelopoulos SD, Zakynthinos SG. Authorship Credit for Large Clinical Trials—Reply. JAMA. 2018;319(7):723–724. doi:10.1001/jama.2017.20943
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: